Beverly Schmocker, R.N., CCRP


Clinical Coordinator, G. I. Oncology

Beverly SchmockerBeverly Schmocker has been the coordinator of numerous national and international GI oncology clinical trials at MSH since 1992. Currently, a prospective, multicentre, randomized clinical trial with Dr. Steven Gallinger as the principal investigator is being conducted to assess the impact of PET Scans prior to liver resection.

Additional studies include:

  • A novel approach for the treatment of Unresectable Hilar Cholangiocarcinoma (bile duct cancer).  Patients are treated with high doses of chemo/radiation, followed by a  liver transplant.
  • The impact of Primovist MRI imaging prior to liver resection fro metastatic colorectal cancer following chemotherapy treatment.
  • Novel therapy utilizing Radiofrequency Ablation (RFA) of large liver tumors in patients undergoing liver resection for metastatic colorectal cancer.
  • A Phase 11 study of Perioperative Chemotherapy plus Panitumumab in patients with colorectal cancer liver metastases.

Mount Sinai Hospital
Zane Cohen Centre for Digestive Diseases
Familial Gastrointestinal Cancer Registry (FGICR)
Ontario Pancreas Cancer Study (OPCS)